News

NervGen Pharma Announces First Subject Dosed in Landmark Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury

Chronic spinal cord injury cohort results expected in mid-2024 Subacute spinal cord injury cohort results expected in late 2024/early 2025Vancouver,…

2 years ago

HPC Announced ‘HPC ROCKS COEUR D’ALENE’ Event During 2023 MCRA Annual Conference

HPC recently hosted its annual 'HPC ROCKS COEUR D'ALENE' Event at the 2023 MCRA Annual Conference.COEUR D'ALENE, ID / ACCESSWIRE…

2 years ago

Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement

Proceeds to fund company's clinical trials, commercial product launch, and working capital Initial conversion price set at $1.50 per shareSAN…

2 years ago

New Campaign from Arcutis Aims to Educate, Raise Awareness, and Provide Encouragement for Those Living with Seborrheic Dermatitis

WESTLAKE VILLAGE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage company focused on…

2 years ago

Scilex Holding Company announces the State of Indiana Medicaid will add Elyxyb as a preferred agent to its preferred drug list (PDL) effective October 1, 2023

PALO ALTO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating…

2 years ago

Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer

Caren Deardorf Editas Medicine, today announced the appointment of Caren Deardorf as the Company’s first Chief Commercial and Strategy Officer.CAMBRIDGE,…

2 years ago

Inovalon to Host Customer Congress in Washington, D.C. October 15-17, 2023

Healthcare Leaders to Convene in Washington, D.C. to Explore Data and Machine Learning’s Impact on Patient Outcomes and EconomicsBOWIE, Md.,…

2 years ago

PharmAla Receives First Office Action for PharmAla-1 PCT Filing

PCT Examiner Finds Molecule to be both Novel and InventiveVANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech…

2 years ago

Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss

TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully completed…

2 years ago

Celldex Therapeutics to Present at Cantor Global Healthcare Conference

HAMPTON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a…

2 years ago